MRNA

2026Q1BMO

Moderna Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-05-01 · Fiscal end 2026-03-31 · Features as of 2026-04-30

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-2.11
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move4.2%
IV front—
P/C full—
P/C front—
Features as of2026-04-30

Run-up

Close—
Ret 5d-13.1%
Ret 10d-16.0%
Ret 20d-8.2%
Ret 30d-12.3%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-3.40Miss
Estimated EPS-2.11
Actual revenue
389.0M
Surprise %-61.1%
Beat / missMiss
Beat streak 40
Beat streak 80

Reaction

1-day stock reaction-2.7%
Implied vs actual

Implied 4.2%Actual 1.5%

Gap reaction+1.5%
Day result-1.2%
Next-day upNo
Realized / IV0.36×

Post tape

Post 5d+19.8%
Post 10d+8.1%
Post volume10.2M
Vol ×10d1.74×
Vol ×20d1.88×
Post range10.1%